Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
35
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
13 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Neogen
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Food Safety Testing Advances Will Expand Global Opportunities
Key Takeaways Regulatory changes and rising food safety concerns are fueling increased adoption of Neogen's core diagnostic technologies, expanding its market and driving durable revenue growth. Portfolio streamlining and operational improvements position Neogen for higher-margin, higher-quality earnings and sustainable competitive gains through innovation and international expansion.
View narrative
US$6.50
FV
13.2% undervalued
intrinsic discount
-1.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
10 days ago
author updated this narrative
Radico Khaitan
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
UK India FTA And Premium Demand Will Spur Market Expansion
Key Takeaways Favorable regulatory shifts and capacity expansions are driving improved margins, increased operating leverage, and greater access to key markets. Strong growth in premium segments and dominant positioning in emerging categories support robust revenue gains and brand-driven profit expansion.
View narrative
₹3.12k
FV
6.6% undervalued
intrinsic discount
15.47%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
5 days ago
author updated this narrative
Foraco International
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Expanding Drilling Contracts In Latin America Will Secure Bright Prospects
Key Takeaways Growing demand for metals and successful contract wins are strengthening Foraco's revenue visibility, especially in core markets like the U.S. and Latin America. Investments in proprietary technology and geographic diversification are enhancing operational efficiency, stabilizing margins, and supporting predictable, long-term earnings growth.
View narrative
CA$3.50
FV
45.7% undervalued
intrinsic discount
11.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
22
users have followed this narrative
5 days ago
author updated this narrative
Visteon
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Automotive Displays And Cockpit AI Will Expand Amid Tariff Risks
Key Takeaways Advancements in automotive display technologies and AI solutions drive growth while positioning Visteon as a top supplier in digital cockpit innovations. Strategic focus on high-growth markets and new business wins with key OEMs supports revenue diversification and enhances future earnings.
View narrative
US$122.50
FV
2.4% overvalued
intrinsic discount
3.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
5 days ago
author updated this narrative
Endava
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
AI Capabilities Like Morpheus And Compass Will Leverage Digital Shift For Market Expansion
Key Takeaways Focus on AI capabilities and long-term deals may drive revenue growth, expanding the addressable market and providing earnings stability. Acquisitions and share buyback program aim to boost operational efficiencies and enhance shareholder value through synergies and increased EPS.
View narrative
US$24.16
FV
43.3% undervalued
intrinsic discount
4.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
24
users have followed this narrative
Updated
narrative
Coherus Oncology
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Biosimilar Setbacks Will Curb Returns But Slight Hope Endures
Key Takeaways Heavy reliance on a few late-stage products and uncertain clinical outcomes create significant risk for both revenue and earnings sustainability. Downward pricing pressure, biosimilar competition, and slow product uptake threaten long-term profitability despite innovation and new market strategies.
View narrative
US$1.10
FV
11.8% overvalued
intrinsic discount
-51.15%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Hexagon Purus
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Green Hydrogen Delays Will Dampen Market Potential Amid Battery Competition
Key Takeaways Overreliance on government incentives and slow hydrogen infrastructure adoption threaten revenue stability, while intensifying battery-electric competition challenges long-term market potential. High R&D spending, ongoing restructuring, and volatile industry conditions undermine profitability and risk further shareholder dilution without margin or cash flow improvement.
View narrative
NOK 1.70
FV
5.4% overvalued
intrinsic discount
17.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Alector
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Overvaluation Will Deflate Prospects In A Niche Neurology Market
Key Takeaways Alector's limited target market and intense pricing pressures threaten future revenue growth and profit potential, even with successful regulatory outcomes. Persistent financial losses and competition from larger biotech firms increase risks of dilution, delays, and challenges in attracting resources and partnerships.
View narrative
US$1.00
FV
152.0% overvalued
intrinsic discount
-43.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Inseego
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Fierce Pricing Battles And Commoditized Hardware Will Erode Standalone Relevance
Key Takeaways Intense competition and industry shifts toward integrated solutions threaten Inseego's market relevance, margins, and long-term earnings stability. Heavy dependence on a few customers and slow progress in transitioning to recurring software revenue expose the company to volatile growth and margin risk.
View narrative
US$8.00
FV
38.0% overvalued
intrinsic discount
4.43%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Value any company in seconds
Popular companies